Real-time enrollment status for this copd clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:49 PM UTC
| NCT Number | NCT06878261 |
| Recruiting Status | Recruiting |
| Condition | COPD |
| Phase | PHASE3 |
| Target Enrollment | 990 participants |
| Active Locations | 80 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 9, 2026 (6 days ago) |
As of October 15, 2026: Clinical trial NCT06878261 is currently recruiting participants. This phase3 study for copd is actively seeking new participants at 80 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06878261 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 80 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06878261 was last updated 6 days ago (October 9, 2026). HelloStudys verifies this status automatically.